Paper33735567
Theoretical and Mechanistic Validation of Global Kinetic Parameters of the Inactivation of GABA Aminotransferase by OV329 and CPP-115.
Weerawarna PM and 2 others. ACS Chem Biol, 2021. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Theoretical and Mechanistic Validation of Global Kinetic Parameters of the Inactivation of GABA Aminotransferase by OV329 and CPP-115. Papers, record 33735567. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33735567
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| 4-Aminobutyrate Transaminase | Major topic |
| Proline | Major topic |
| Catalysis | |
| Kinetics | |
| Molecular Dynamics Simulation | |
| Quantum Theory | |
| Reproducibility of Results |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 DA030604 | NIDA NIH HHS | United States | R01DA030604 | PubMed and NIH | NIH RePORTER |
| R01 NS123057 | NINDS NIH HHS | United States | R01NS123057 | PubMed | NIH RePORTER |
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29876439 | Data characterizing the energetics of enzyme-catalyzed hydrolysis and transglycosylation reactions by DFT cluster model calculations. | Data Brief | 2018 | https://conductscience.org/library/papers/29876439 | PubMed |
| 2 | 24121043 | Aspartate aminotransferase: an old dog teaches new tricks. | Arch Biochem Biophys | 2014 | https://conductscience.org/library/papers/24121043 | PubMed |
| 3 | 10691696 | A new class of conformationally rigid analogues of 4-amino-5-halopentanoic acids, potent inactivators of gamma-aminobutyric acid aminotransferase. | J Med Chem | 2000 | https://conductscience.org/library/papers/10691696 | PubMed |
| 4 | 23407358 | GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit. | Bioinformatics | 2013 | https://conductscience.org/library/papers/23407358 | PubMed |
| 5 | 16350889 | Evaluation of enzyme inhibitors in drug discovery. A guide for medicinal chemists and pharmacologists. | Methods Biochem Anal | 2005 | https://conductscience.org/library/papers/16350889 | PubMed |
| 6 | 19640775 | Pyridoxal 5'-phosphate: electrophilic catalyst extraordinaire. | Curr Opin Chem Biol | 2009 | https://conductscience.org/library/papers/19640775 | PubMed |
| 7 | 23373756 | Heavy-enzyme kinetic isotope effects on proton transfer in alanine racemase. | J Am Chem Soc | 2013 | https://conductscience.org/library/papers/23373756 | PubMed |
| 8 | 3794716 | Deuterium isotope effect in gamma-aminobutyric acid transamination: determination of rate-limiting step. | J Neurochem | 1987 | https://conductscience.org/library/papers/3794716 | PubMed |
| 9 | 25616005 | Mechanism of inactivation of γ-aminobutyric acid aminotransferase by (1S,3S)-3-amino-4-difluoromethylene-1-cyclopentanoic acid (CPP-115). | J Am Chem Soc | 2015 | https://conductscience.org/library/papers/25616005 | PubMed |
| 10 | 7791614 | Mechanism-based enzyme inactivators. | Methods Enzymol | 1995 | https://conductscience.org/library/papers/7791614 | PubMed |
| 11 | 11671397 | Kinetic Isotope Effects and Transition State Geometries. A Theoretical Investigation of E2 Model Systems. | J Org Chem | 1997 | https://conductscience.org/library/papers/11671397 | PubMed |
| 12 | 4202581 | Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. | Biochem Pharmacol | 1973 | https://conductscience.org/library/papers/4202581 | PubMed |
| 13 | 14022996 | Semicarbazone formation from pyridoxal, pyridoxal phosphate, and their Schiff bases. | Biochemistry | 1962 | https://conductscience.org/library/papers/14022996 | PubMed |
| 14 | 29381352 | Design and Mechanism of (S)-3-Amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic Acid, a Highly Potent γ-Aminobutyric Acid Aminotransferase Inactivator for the Treatment of Addiction. | J Am Chem Soc | 2018 | https://conductscience.org/library/papers/29381352 | PubMed |
| 15 | 17242351 | Ligand configurational entropy and protein binding. | Proc Natl Acad Sci U S A | 2007 | https://conductscience.org/library/papers/17242351 | PubMed |
| 16 | 28510452 | Rational Optimization of Mechanism-Based Inhibitors through Determination of the Microscopic Rate Constants of Inactivation. | J Am Chem Soc | 2017 | https://conductscience.org/library/papers/28510452 | PubMed |
| 17 | 22183545 | Linear interaction energy: method and applications in drug design. | Methods Mol Biol | 2012 | https://conductscience.org/library/papers/22183545 | PubMed |
| 18 | 14033211 | Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase. | J Biol Chem | 1962 | https://conductscience.org/library/papers/14033211 | PubMed |
| 19 | 30009604 | Synthesis of ( S)-3-Amino-4-(difluoromethylenyl)-cyclopent-1-ene-1-carboxylic Acid (OV329), a Potent Inactivator of γ-Aminobutyric Acid Aminotransferase. | Org Lett | 2018 | https://conductscience.org/library/papers/30009604 | PubMed |
| 20 | 17691728 | Intrinsic primary and secondary hydrogen kinetic isotope effects for alanine racemase from global analysis of progress curves. | J Am Chem Soc | 2007 | https://conductscience.org/library/papers/17691728 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41754847 | Discovery of Plant-Derived Natural Compounds as Novel GABA Aminotransferase Inhibitors: Structure-Based Discovery, Experimental Validation, and Molecular Dynamics Analysis. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/41754847 | PubMed |
| 41711325 | Targeting Conformational Flexibility of a Reactive Intermediate to Enhance Selectivity of a GABA Aminotransferase Inactivator. | J Am Chem Soc | 2026 | https://conductscience.org/library/papers/41711325 | PubMed |
| 39793055 | Efficacy of GABA aminotransferase inactivator OV329 in models of neuropathic and inflammatory pain without tolerance or addiction. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/39793055 | PubMed |
| 38937107 | Sustained Inhibition of GABA-AT by OV329 Enhances Neuronal Inhibition and Prevents Development of Benzodiazepine Refractory Seizures. | eNeuro | 2024 | https://conductscience.org/library/papers/38937107 | PubMed |
| 36770800 | Structural and Mechanistic Basis for the Inactivation of Human Ornithine Aminotransferase by (3S,4S)-3-Amino-4-fluorocyclopentenecarboxylic Acid. | Molecules | 2023 | https://conductscience.org/library/papers/36770800 | PubMed |
| 35293728 | Rational Design, Synthesis, and Mechanism of (3S,4R)-3-Amino-4-(difluoromethyl)cyclopent-1-ene-1-carboxylic Acid: Employing a Second-Deprotonation Strategy for Selectivity of Human Ornithine Aminotransferase over GABA Aminotransferase. | J Am Chem Soc | 2022 | https://conductscience.org/library/papers/35293728 | PubMed |
| 35059122 | Inactivators of Ornithine Aminotransferase for the Treatment of Hepatocellular Carcinoma. | ACS Med Chem Lett | 2022 | https://conductscience.org/library/papers/35059122 | PubMed |
| 34617595 | OV329, a novel highly potent γ-aminobutyric acid aminotransferase inactivator, induces pronounced anticonvulsant effects in the pentylenetetrazole seizure threshold test and in amygdala-kindled rats. | Epilepsia | 2021 | https://conductscience.org/library/papers/34617595 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABAT | 18 | PubTator's text mining | https://conductscience.org/library/genes/18 | NCBI Gene |
| CNR1 | 1268 | PubTator's text mining | https://conductscience.org/library/genes/1268 | NCBI Gene |
| CYP4F3 | 4051 | PubTator's text mining | https://conductscience.org/library/genes/4051 | NCBI Gene |
| KCNH2 | 3757 | PubTator's text mining | https://conductscience.org/library/genes/3757 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33735567
GET https://conductscience.org/api/papers/v1/33735567/references?page=2